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http://dx.doi.org/10.1016/j.fjs.2013.Summary Background: Adipose-derived stromal/progenitor cells (ADSCs) are of great inter-
est because of their unique capacity for prolonged or unlimited self-renewal and their ability
to differentiate into multiple lineages. Combining ADSCs with biomaterial scaffolds provides a
promising strategy for cellular delivery and tissue engineering.
Objectives: A wide range of biomaterials have been developed for different applications. We
here evaluate the current commercially available medical materials as scaffolds in combina-
tion with rat ADSCs for tissue engineering applications.
Methods: Experiments (anchorage independent growth, gap junctional intercellular communi-
cation, multilineage differentiation, cell-surface marker, and reverse transcription polymerase
chain reaction) were performed to prove these primary cultured cells had the same character-
istics as ADSCs. Twelve kinds of medical materials were then used as scaffolds to see which
ADSCs can grow and develop.
Results: The cultured Wistar rat cells had the characteristics of stems cells, including a high
frequency of anchorage-independent growth in soft agar and a lack of gap junctional intercel-
lular communication in cell type with serpiginous morphology. These cells can be differenti-
ated into adipocytes and osteocytes after induction. The differentiated phenotypes were
verified by morphology, special stains, as well as detection of tissue-specific mRNA. In addi-
tion, these ADSCs could grow into the Kaltostat, CollaWound, Tissucol Duo Quick (Baxter),
and Spongostan Dental after 144 hours incubation.ave no conflicts of interest relevant to this article.
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2 Y.-T. Sheen et al.Conclusion: Kaltostat, CollaWound, Tissucol Duo Quick (Baxter), and Spongostan Dental have
better biocompatibility and can be considered as scaffold materials for future clinical
research.
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reserved.1. Introduction
Adipose-derived stromal/progenitor cells (ADSCs) were first
described by Zuk et al1 and have the capacity for prolonged
or unlimited self-renewal and ability to differentiate into
multiple lineages.2e4 It can achieve lower donor site mor-
bidity.5e7 Compared with other sources of mescenchymal
stem cells, we believe that ADSCs are the best choice for
clinical use because they are easier to harvest from adipose
tissue than bone marrow and there are plenty of fat sources
in the human body.5e7 Moreover, there are fewer ethical is-
sues in using cells from fat tissue than those harvested from
human embryos. Therefore we studied the ADSCs as the
material instead of hematopoietic stem cell transplantation.
Development of scaffolds has demonstrated promise for
tissue engineering applications and can be used as re-
placements for lost or damaged tissues.8 Such biomaterial
scaffolds provide a three-dimensional structure for stem
cells to be implanted to develop tissue. A wide variety of
natural and synthetic materials and composite mixtures of
materials have been investigated as scaffolds for tissue
regeneration.9 As plastic surgeons do not have access to
chemical techniques to invent new material or the ability
to complete the complicated Phase I/II/III clinical trials for
new human use material, we used medical materials that
have already been approved for human use. We evaluated
the current commercially available medical materials as
scaffolds in combination with rat ADSCs to verify their
biocompatibility.
2. Materials and methods
2.1. Harvesting of fat tissue from rats
Male Wistar rats (n Z 6) weighing 300e400 g were used in
this study. The animal use protocol listed below has been
received and approval by the Institutional Animal Care and
Use Committee (IACUC). After rats were anesthetized by
intraperitoneal injection of Zoletil 50 (Virbac Taiwan Co,
Ltd, Taipei, Taiwan), inguinal skin was prepared and sub-
cutaneous fatty tissue around 10 g was resected from the
right or left inguinal area. These adipose tissues were
rinsed with D-phosphate-buffered saline (D-PBS) to remove
the majority of erythrocytes. Tissues were scraped into a
tube, washed in D-PBS and centrifuged at 750 g for 5 mi-
nutes. The preparation procedures were as described by Lin
et al.10 The upper fraction was transferred to another tube
using a sterile pipette and washed. After centrifugation,
the tissue was distributed into tubes containing Dulbecco’s
modified Eagle medium (DMEM) with 1 mg/mL collagenase,
2 mM n-acetylcysteine, and 0.2 mM ascorbic acid 2-
phosphate. After incubation at 37C for 3 hours, tubeswere centrifuged at 750g for 5 minutes to remove the
collagenase solution and the pellet was washed and then
incubated in DMEM with 10% fetal bovine serum (FBS), 2 mM
NAC, and 0.2 mM ascorbic 2-phosphate in a 5% CO2 incu-
bator. After 24 hours, the unattached cells were removed
by washing with PBS. Then, 5 mL of K-NAC medium with 5%
FBS were added to each 25-cm2 flask. The medium was
changed every other day until confluence. These cells were
generated for trypsinization and stored in liquid nitrogen or
kept for subculturing.
2.2. Anchorage independent growth
A total of 50,000 cells in 3 mL of 0.33% agarose medium
were plated on top of 3-mL of prehardened 0.5% agarose
medium in each of triplicate dishes (6 cm). Then, 2.5 mL of
liquid medium (K-NAC with 5% FBS) were added and
renewed once every 3 days. At the end of 3 weeks, the
numbers of colonies developed were scored under a mi-
croscope with the dish containing anchorage independent
growth colonies on the top of a dish with grids. The prep-
aration procedures were as described by Lin et al.10
2.3. Gap junctional intercellular communication
The gap junctional intercellular communication (GJIC) was
studied by scrape loading/dye transfer technique.10e13 The
dye transfer between cells was observed using a Nikon
Eclipse TE300UVfluorescencemicroscope; Tokyo, Japan and
recorded by a digital camera connected to a computer. The
preparation procedures were as described by Lin et al.10
2.4. Multilineage differentiation: adipogenesis and
osteogenesis
For differentiation induction of putative ADSCs into adipo-
cytes and osteoblasts, the cells were initially developed and
propagated by different supplementations in DMEM,1,10,14,15
following the induction procedure reported by Lin et al.10
2.5. Reverse transcriptase-polymerase chain
reaction
Reverse transcription (RT) of the RNA was performed in a
20-mL reaction mixture using a poly-T primer with 20 U
SuperScript, 10 mM dNTP mix, 0.5 mM bovine serum albu-
min, 1 M dithiothreitol, and supplied buffer. The mixture
was incubated at 42C for 1 hour and at 94C for 10 minutes
to inactivate the RT. One-tenth of this reaction was added
to a standard polymerase chain reaction (PCR) mixture with
tissue-specific primers, dNTP mix, bovine serum albumin,
Taq buffer, and Taq polymerase. PCR products were
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Scaffold candidates for ADSC tissue engineering 3resolved on a 2% agarose gel stained with ethidium bro-
mide. The preparation procedures were as described by
Tholpady et al.16
2.6. Fluorescence-activated cell sorting analysis of
ADSCs
In order to determine the charateristics of these primary
cultured cells, the ADSCs within three passages were har-
vested by trypsinization, and then the cells were fixed in
neutralized 2%paraformaldehyde solution for 30minutes.The
fixed cells were washed twice with PBS and incubated with
antibodies against CD90, CD29, CD34, CD31, and CD45 for
30 minutes.2 Primary antibodies were directly conjugated
with fluorescein isothiocyanate (FITC) and phycoerythrin. For
isotype control, nonspecific FITC-conjugated immunoglobulin
G was substituted for the primary antibodies.
2.7. Verification of scaffold biocompatibility
Tissue engineering holds promise in medicine by combining
scaffolds, cells, and growth factors. The tissue engineering
implant can also be integrated into the existing tissue,
resulting in a seamless transition between the two. This
advantage can be mostly attributed to the development of
biomimetic scaffolds. Using the current available medical
materials, we tested whether the ADSCs can grow into the
three-dimensional environment that scaffolds provide. We
tested 12 different kinds of scaffold including Seprafilm
(Genzyme Corporation, Cambridge, MA, USA), Inion (AES-
CULAP Implant System Inc., 3773 Corporate Parkway Center
Valley, PA, USA), CollaWound (2nd Floor, No. 360, Ruiguang
Road, Neihu, Taipei, TW), Intrasite Gel (Smith and Nephew
Medical LTD., 101 Hessle Rd., Hull, UK), DuoDERM (Conva
Tec, Division of E. R. Squibb & Sons, L.L.C., Princeton, NJ,
USA), Surgicel (Johnson & Johnson Medical Ltd., UK),
Spongostan Dental (Johnson & Johnson Medical Ltd., UK),
Kaltostat (Britcair, Aldershot, Hants, UK), Medpor (Pores
Surgical Inc., College Park, GA, USA), and Tissucol Duo
Quick (Baxter AG, Vienna, Austria) (Table 1). Bolus injec-
tion of cell suspension (5  106 cells/mL) into these scaf-
folds were performed and cultured in a 5% CO2 incubation
for 24 hours. The preliminary data showed that ADSCs could
grow into Kaltostat, Tissucol Duo Quick, CollaWound, and
Spongostan Dental. Therefore, a second experiment was
performed. We used commercially available Qtracker
(Invitrogen, Inc., Hayward, CA, USA) to label the ADSCs.
Then, 5  106 cells/mL ADSCs were bolus injected into
these four scaffolds. On Day 3 and Day 6, fluorescence
microscopy was used to observe these cells. Live cells
labeled with bioconjugated quantum dots (QDs) can be
readily imaged by fluorescent microscopy.17
3. Results
3.1. Development of cell culture from rat adipose
tissue
After 3 hours, the culture of minced adipose tissue in the
DMEM with 10% FBS showed most of the cells remaining in
Figure 1 Under (A) 40 and (B) 400 magnification, the morphology is serpiginous or has a fibroblast-like appearance, which is
similar to human adipose-derived stromal/progenitor cells. (C) Under 200 magnification, one can see cells undergo anchorage-
independent division to form a colony on soft agar. (D) With adipogenic differentiation, the bright lipid vacuoles are clearly
visible without staining under 100magnification. (E) With osteogenic differentiation, deposits of calcified extracellular matrix are
clearly seen with Alizarin Red staining under 100 magnification.
4 Y.-T. Sheen et al.suspension, including many erythrocytes. After washing
procedures, few attached cells proliferated actively and
became confluence after 1 week in 25-cm2 flasks. These
putative ADSCs appeared serpiginous or fibroblast-like
appearance microscopically11 (Fig. 1A and B).3.2. Verification of rat ADSCs3.2.1. Anchorage independent growth
Stem cells and cancer cells are capable of growing in soft
agar; by contrast, ordinary cells are not able to grow on soft
agar.10,18 The result showed these rat adipose-derived cells
can undergo anchorage-independent division to form a
colony on soft agar (Fig. 1C), whereby we can differentiate
stem cells from fibroblasts.11Figure 2 After 3 hours, strong Lucifer Yellow dye is still retain
serpiginous cells with fluorescent microscopy.3.3. Induction of multilineage differentiation
3.3.1. Adipogenesis
After treatment with 3-isobutyl-1-methylxanthine, dexa-
methasone, indomethacin, and insulin for 3 days and insulin
for 1 day, lipid-producing adipocytes appeared after one
cycle of treatment.10,15 The lipid vacuoles became larger
after two or three cycles of treatment and were clearly
visible without staining under a microscope (Fig. 1D). The
ability of these cells to differentiate into adipocytes is
similar to ADSCs.11
3.3.2. Osteogenesis
After treatment with dexamethasone, Asc-2P, and b-glyc-
erophosphate in D-medium for 2e4 weeks, the cell mono-
layer was covered with a layer of visible deposits. Throughed in the gap junction intercellular communication-deficient
Figure 3 Reverse transcription polymerase chain reaction
results for genes tested against cells exposed to different
conditions: (A) when treated with osteogenic media, cells are
positive for osteonectin. (B) In adipogenic media, peroxisome
proliferator activated receptor g is expressed after 21 days of
culture. Glyceraldehyde-3-phosphate dehydrogenase is used as
a control.
Scaffold candidates for ADSC tissue engineering 5Alizarin Red staining, it has shown that these deposits are
calcified extracellular matrix (Fig. 1E), which indicates that
these cells retain the ability of osteogenic differentiation.3.3.3. GJIC
Cancer cells and many adult human stem cells have been
shown to have GJIC.10,19e22 The ADSCs were studied by
Lucifer Yellow scrape loading/dye transfer technique. The
result shows these serpiginous cells were deficient in dye
transfer (Fig. 2A and B). This characteristic shows that
these cells are similar to ADSCs.113.3.4. RT-PCR
Undifferentiated ADSCs were induced to differentiate
through the adipogenic or osteoblastic pathways, and were
then analyzed for the presence of tissue-specific mRNA by
RT-PCR. Both cell types were assayed after 4 weeks. Spe-
cific markers for these cell types were peroxisome pro-
liferator activated receptor g (adipocytes) and osteonectin
(osteoblasts).14
In the RT-PCR analysis, ADSCs grown in adipogenic media
were positive only for peroxisome proliferator activated
receptor g (Fig. 3A), but not for other markers. When
treated with osteogenic media, ADSCs were positive for
osteonectin (Fig. 3B). The PCR results were consistent with
the morphology and cell-type-specific staining in deter-
mining the differentiated cell type.Figure 4 Fluorescence-activated cell sorting analysis of rat ADS
expressed CD90, CD34, and CD29 markers but were negative for C3.4. Fluorescence-activated cell sorting
Fluorescence-activated cell sorting analysis of rat ADSCs (3
passages) using mouse monoclonal antibodies: specific FITC
and phycoerythrin conjugated antibodies against surface
markers. An isotype control was included in each test (gray
lines). The result showed that they expressed CD90, CD34,
andCD29markers but did not express CD31 andCD45markers
(Fig. 4). Fluorescence-activated cell sorting analysis of sur-
facemarkerswasconsistent formesenchymal stemcells. This
result was compatible with other reports.2,23e25
3.5. Verification of scaffold biocompatibility
Bolus injection of the suspension of ADSCs (5  106 cell/mL)
into the scaffold was performed. The scaffolds were
immersed with culture medium and put in a 5% CO2 incu-
bator for 24 hours. Cells were able to attach to and form a
three-dimensional structure in Kaltostat, Tissucol Duo
Quick, CollaWound, and Spongostan Dental (Fig. 5). How-
ever, ADSCs were unable to attach to the other materials
and cell death was observed (Fig. 6). QD signals were
detected in Kaltostat (Fig. 7), Tissucol Duo Quick (Fig. 8),
CollaWound (Fig. 9), and Spongostan Dental (Fig. 10) at 72
hours and 144 hours.4. Discussion
Ideal repair after soft tissue injury is a challenge in plastic
reconstruction surgery. Using a patient’s own mesenchymal
stem cells to regenerate the tissue offers a new solution to
restore soft tissue defect with less donor site morbidity.
Concerning the cell source, fibroblasts are important in
collagen synthesis and remodeling, but the main disad-
vantages are their limited lifespan, capacity for prolifera-
tion, and narrow usage due to their differentiated state.26
Adipose tissue, however, is an abundant and accessible
source of adult stem cells and can be collected under local
anesthesia with less donor site morbidity. Immunomodula-
tory capacity and less immune reaction make ADSCs a
greater potential for transplantation.26,27 Collectively,
these beneficial features together with a lack of ethical
concerns have promoted ADSCs to the forefront of tissue
engineering.5e7,28
We successfully isolated a group of Wistar rat cells from
the subcutaneous fatty tissue and proved that these cells
have the characteristics of ADSCs.
Creating and maintaining the shape and dimensions of
the engineered soft tissue are perhaps best accomplished
by scaffold biomaterials.29 Most scaffolds provide a three-Cs population expanded to three passages. Most of the cells
D31 and CD45 markers.
Figure 5 Under 200 magnification, cells can seen to be attached to the following materials and forming three-dimensional
structures: (A) Kaltostat; (B) Tissucol Duo Quick; (C) CollaWound; (D) Spongostan Dental at 24 hours.
6 Y.-T. Sheen et al.dimensional environment in which tissue can grow and
develop. ADSCs can be expanded in culture and introduced
into scaffolds to form tissues prior to or after differentia-
tion. The engineered tissue structure can then be inserted
into the body to repair the soft tissue defect. For example,
calcium phosphate has been used for bone tissue engi-
neering because of its pore network and ability to bond
with bone.9 Hydro gel is regarded as an injectable scaffold
to introduce cell into the solution prior to gelation.9
Three-dimensional scaffold has been considered as a key
factor to obtain high differentiation, proliferation rate, and
growth stability.9 However, it is a challenge to find anFigure 6 Under 100 magnification, no cells attached to or form
the following materials: (A) Seprafilm; (B) Medpor; (C) DuoDERM; (
Inion plate; (H) Surgicel.appropriate scaffold that should promote cell adhesion,
proliferation, and differentiation and at the same time not
develop an immune reaction. A wide range of biomaterials
has been developed for different applications. However,
the Phase I/II/ III clinical trials for developing human-use
materials are very complicated and may need more than
10 years to complete. To avoid expensive and time-
consuming clinical trials in humans for testing the
biocompatible scaffolds, we choose 12 kinds of current
commercially available medical materials to verify their
biocompatibility. We found that ADSCs could grow into
Kaltostat, CollaWound, Tissucol Duo Quick, and Spongostaned three-dimensional structures and cell death is observed in
D) Surgicel Fibriller; (E) Intrasite Gel; (F) Surgicel Nu-Knit; (G)
Figure 7 Kaltostat. (A) Bright-field and (B) fluorescent images of the same view show adipose-derived stromal/progenitor cells
labeled with quantum dots (red spots) at 72 hours. (C) Bright-field and (D) fluorescent images of the same view show adipose-
derived stromal/progenitor cells labeled with quantum dots (red spots) at 144 hours. All magnifications: 40.
Figure 8 Tissucol Duo Quick. (A) Bright-field and (B) fluorescent images of the same view show adipose-derived stromal/pro-
genitor cells labeled with quantum dots (red spots) at 72 hours. (C) Bright-field and (D) fluorescent images of the same view show
adipose-derived stromal/progenitor cells labeled with quantum dots (red spots) at 144 hours. All magnifications: 40.
Scaffold candidates for ADSC tissue engineering 7
Figure 9 CollaWound. (A) Bright-field and (B) fluorescent images of the same view show adipose-derived stromal/progenitor cells
labeled with quantum dots (red spots) at 72 hours. (C) Bright-field and (D) fluorescent images of the same view show adipose-
derived stromal/progenitor cells labeled with quantum dots (red spots) at 144 hours. All magnifications: 40.
Figure 10 Spongostan (A) Bright-field and (B) fluorescent images of the same view show adipose-derived stromal/progenitor cells
labeled with quantum dots (red spots) at 72 hours. (C) Bright-field and (D) fluorescent images of the same view show adipose-
derived stromal/progenitor cells labeled with quantum dots (red spots) at 144 hours. All magnifications: 40.
8 Y.-T. Sheen et al.
Scaffold candidates for ADSC tissue engineering 9Dental after 144 hours’ incubation. Kaltostat is a calcium
sodium alginate made from brown seaweed and provides a
moist healing environment and hemostasis.30 CollaWound is
composed of pure collagen and provides a provisional ma-
trix in the wound cavity to act as a scaffold for the ingrowth
of cells involved in normal healing process. Tissucol Duo
Quick is based on the final stage of coagulation, specifically
the conversion by thrombin, factor XIII, and calcium of a
fibrinogen monomer into a fibrin polymer, to create a he-
mostatic adhesive clot. Spongostan Dental is an absorbable
gelatin sponge with a hemostatic effect for surgical and
dental purposes. These four biomaterials are commercially
available, nonallergic to patients, biocompatible, and
easily packed into the defect site; all can be regarded as
good material candidates for future experiments.
4.1. Study limitations
This is a preliminary report for testing the potential scaf-
folds that can be used in humans. However, several limi-
tations in the design of this study can be identified. First,
our results only showed the early cell-scaffold response
rather than any long-term tissue changes and formation.
The growth rate and proliferation potential of ADSCs in
these scaffolds were not specifically studied. Second,
because the total amount of Qtracker is a constant number,
further proliferation of ADSCs will dilute the density of
Qtracker. Thus, this study design is not able to show the
quantity change of ADSCs in these scaffolds. Third, the
Qtracker can only be detected within 2 weeks; we need a
different ADSC tracking technique to observe the position
and quantity of ADSCs for more than 2 weeks. Furthermore,
cell viability and differentiation in these scaffolds will need
further investigation by immune staining techniques in
future studies. The conclusions should be interpreted with
these limitations in mind.5. Conclusion
We successfully isolated rat ADSCs and then verified the
biocompatibility potential of available scaffold’s. Kalto-
stat, CollaWound, Tissucol Duo Quick (Baxter), and Spon-
gostan Dental have good biocompatibility and can be
considered as scaffold materials for future clinical
research.Acknowledgments
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